Voltar
Artigo Revisado por pares
BIBTEX RIS

PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial

2014; Elsevier BV; Volume: 385; Issue: 9965 Linguagem: Inglês

10.1016/s0140-6736(14)61399-4

ISSN

1474-547X

Autores

Frederick J. Raal, Evan A. Stein, Robert Dufour, Traci Turner, Fernando Civeira, Lesley Burgess, Gisle Langslet, Russell Scott, Anders Olsson, David Sullivan, G. Kees Hovingh, Bertrand Cariou, Ioanna Gouni‐Berthold, Ransi Somaratne, Ian Bridges, Robert C. Scott, Scott M. Wasserman, Daniel Gaudet,

Tópico(s)

Lipoproteins and Cardiovascular Health

Referência(s)